Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q1 2023

Stryker, Johnson & Johnson and Zimmer Biomet posted their first quarter financial results for 2023, and data on their orthopedic sales.

Advertisement

Here is how they compare:

Stryker 

Total sales: $4.8 billion (+11.8 percent) 

Orthopedics and spine: $2.1 billion (+12.7 percent) 

Hips: $375 million (+14.4 percent)

Knees: $566 million (+22 percent)

Spine: $284 million (+1.9 percent)

Johnson & Johnson

Total sales: $24.7 billion (+5.6 percent)

Spine, sports and other: $699 million ( percent) 

Orthopedic: $2.2 billion (+2.6percent) 

Hips: $390 million (+0.4 percent)

Knees: $368 million (+8.7 percent)

Zimmer Biomet

Total sales: $1.8 billion (+10.1 percent)

Hips: $492.8 million (+9.3 percent) 

Knees: $762.5 million (+15 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $433.4 million (+4 percent)

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.